(Q38432028)

3 September 2017

1 reference

title

Stem Cell-Based Therapy in Idiopathic Pulmonary Fibrosis (English)

1 reference

3 September 2017

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25896401%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

author name string

Marek Barczyk

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25896401%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Matthias Schmidt

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25896401%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

publication date

1 August 2015

1 reference

Stem Cell Reviews and Reports

3 September 2017

published in

1 reference

3 September 2017

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25896401%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25896401%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

598-620

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25896401%20AND%20SRC:MED&resulttype=core&format=json

Environmental, inhaled and ingested causes of pulmonary fibrosis

9 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Pulmonary fibrosis: pathogenesis, etiology and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Does current knowledge explain the pathogenesis of idiopathic pulmonary fibrosis? A perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Murine models of pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Progress toward improving animal models for idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Clinical review: idiopathic pulmonary fibrosis acute exacerbations--unravelling Ariadne's thread

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Viral infection in acute exacerbation of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Therapy for fibrotic diseases: nearing the starting line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

A new hope for idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Lung Transplant in Idiopathic Pulmonary Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010-2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Mesenchymal stem cells and idiopathic pulmonary fibrosis. Potential for clinical testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Cell therapy trials for lung diseases: progress and cautions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Stem cells and pulmonary fibrosis: cause or cure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Therapeutic potential of lung epithelial progenitor cells derived from embryonic and induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Designing materials to direct stem-cell fate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Histologic spectrum of idiopathic interstitial pneumonias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Evidence of type II pneumocyte apoptosis in the pathogenesis of idiopathic pulmonary fibrosis (IFP)/usual interstitial pneumonia (UIP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Abnormal expression of telomerase/apoptosis limits type II alveolar epithelial cell replication in the early remodeling of usual interstitial pneumonia/idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

The epithelium in idiopathic pulmonary fibrosis: breaking the barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Fibrosis of two: Epithelial cell-fibroblast interactions in pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Idiopathic pulmonary fibrosis: update on genetic discoveries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Genetic studies provide clues on the pathogenesis of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Molecular mechanisms in progressive idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Telomeres and age-related disease: how telomere biology informs clinical paradigms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

A first glimpse at the early origins of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Lack of MK2 inhibits myofibroblast formation and exacerbates pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Aberrant differentiation of fibroblast progenitors contributes to fibrosis in the aged murine heart: role of elevated circulating insulin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Extracellular matrix remodelling properties of human fibrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

The role of a human hematopoietic mesenchymal progenitor in wound healing and fibrotic diseases and implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

The role of fibrocytes in fibrotic diseases of the lungs and heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Identification of a cell-of-origin for fibroblasts comprising the fibrotic reticulum in idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Stem cells and regenerative medicine in lung biology and diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Intratracheal transplantation of alveolar type II cells reverses bleomycin-induced lung fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Cell-based therapies for lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Adipose-derived mesenchymal stromal/stem cells: An update on their phenotype in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Cell-based therapy in lung regenerative medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Bone marrow-derived mesenchymal stem cells in repair of the injured lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Therapeutic effects of bone marrow-derived mesenchymal stem cells engraftment on bleomycin-induced lung injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Modulation of cytokine and nitric oxide by mesenchymal stem cell transfer in lung injury/fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Bone marrow stem cells expressing keratinocyte growth factor via an inducible lentivirus protects against bleomycin-induced pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Mesenchymal stem cells stably transduced with a dominant-negative inhibitor of CCL2 greatly attenuate bleomycin-induced lung damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

HGF Expressing Stem Cells in Usual Interstitial Pneumonia Originate from the Bone Marrow and Are Antifibrotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

The effect of adipose stem cell therapy on pulmonary fibrosis induced by repetitive intratracheal bleomycin in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Transplantation of human embryonic stem cell-derived alveolar epithelial type II cells abrogates acute lung injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

CD166(pos) subpopulation from differentiated human ES and iPS cells support repair of acute lung injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

A novel genomic signature with translational significance for human idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Injured microenvironment directly guides the differentiation of engrafted Flk-1(+) mesenchymal stem cell in lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Bone marrow origin of myofibroblasts in irradiation pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the Internatio

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

The regulatory sciences for stem cell-based medicinal products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Manufacture of clinical grade human placenta-derived multipotent mesenchymal stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Isolation of amniotic stem cell lines with potential for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Renal differentiation of amniotic fluid stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Human amniotic fluid stem cells can integrate and differentiate into epithelial lung lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Stem-cell therapy in an experimental model of pulmonary hypertension and right heart failure: role of paracrine and neurohormonal milieu in the remodeling process

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Human amniotic fluid as a potential new source of organ specific precursor cells for future regenerative medicine applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Embryonic stem cell lines derived from human blastocysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

A pure population of lung alveolar epithelial type II cells derived from human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Efficient derivation of alveolar type II cells from embryonic stem cells for in vivo application

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Efficient derivation of purified lung and thyroid progenitors from embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Tissue engineering of lung: the effect of extracellular matrix on the differentiation of embryonic stem cells to pneumocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Induction of ciliated cells from avian embryonic stem cells using three-dimensional matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Induced pluripotent stem cell lines derived from human somatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

The promise of human induced pluripotent stem cells for research and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Generation of anterior foregut endoderm from human embryonic and induced pluripotent stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Generation of multipotent lung and airway progenitors from mouse ESCs and patient-specific cystic fibrosis iPSCs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Human iPS cell-derived alveolar epithelium repopulates lung extracellular matrix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Progress toward the clinical application of patient-specific pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Inducing iPSCs to escape the dish.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Immunogenicity of induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Virus-free induction of pluripotency and subsequent excision of reprogramming factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Induced pluripotent stem cells generated without viral integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Generation of mouse induced pluripotent stem cells without viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Generation of induced pluripotent stem cells using recombinant proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Generation of mouse-induced pluripotent stem cells by transient expression of a single nonviral polycistronic vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Human induced pluripotent stem cells free of vector and transgene sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Regulations and guidelines governing stem cell based products: Clinical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Soliciting strategies for developing cell-based reference materials to advance mesenchymal stromal cell research and clinical translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Differential efficacy of human mesenchymal stem cells based on source of origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Stem cell conditioned medium improves acute lung injury in mice: in vivo evidence for stem cell paracrine action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Proteomic analysis of microvesicles derived from human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Derivation and characterization of human fetal MSCs: an alternative cell source for large-scale production of cardioprotective microparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Exosomes for drug delivery - a novel application for the mesenchymal stem cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Telomere dynamics in induced pluripotent stem cells: Potentials for human disease modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Cell delivery mechanisms for tissue repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Growth factors, matrices, and forces combine and control stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Comparative decellularization and recellularization of normal versus emphysematous human lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Acellular normal and fibrotic human lung matrices as a culture system for in vitro investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Identification of Spontaneous Feline Idiopathic Pulmonary Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

An official American thoracic society workshop report: comparative pathobiology of fibrosing lung disorders in humans and domestic animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Antifibrotic activities of pirfenidone in animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Acute exacerbations of fibrotic interstitial lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Bioartificial lung engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Perspectives on whole-organ assembly: moving toward transplantation on demand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Immunosuppressive properties of mesenchymal stem cells: advances and applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Mesenchymal-stem-cell-based experimental and clinical trials: current status and open questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Lung transplantation in telomerase mutation carriers with pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Rescue of murine silica-induced lung injury and fibrosis by human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-015-9587-7

Nintedanib and pirfenidone. New antifibrotic treatments indicated for idiopathic pulmonary fibrosis offer hopes and raises questions

21 January 2018

1 reference

12 December 2020

Identification of spontaneous feline idiopathic pulmonary fibrosis: morphology and ultrastructural evidence for a type II pneumocyte defect

1 reference

12 December 2020

Recruitment of host's progenitor cells to sites of human amniotic fluid stem cells implantation

1 reference

12 December 2020

Stem Cells Derived from Human Fetal Membranes Display Multilineage Differentiation Potential

1 reference

12 December 2020

Manufacturing of human placenta-derived mesenchymal stem cells for clinical trials

1 reference

12 December 2020

Bleomycin revisited: towards a more representative model of IPF?

1 reference

12 December 2020

Relationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis

1 reference

12 December 2020

Induced pluripotent stem cell technology in regenerative medicine and biology

1 reference

12 December 2020

A systematic review of preclinical studies on the therapeutic potential of mesenchymal stromal cell-derived microvesicles

1 reference

12 December 2020

In vitro secreting profile of human mesenchymal stem cells

1 reference

12 December 2020

Proteolytic Potential of the MSC Exosome Proteome: Implications for an Exosome-Mediated Delivery of Therapeutic Proteasome

1 reference

12 December 2020

Alveolar epithelial type II cells from embryonic stem cells: knights in shining armour?

1 reference

12 December 2020

Adaptation to culture of human embryonic stem cells and oncogenesis in vivo

1 reference

12 December 2020